Top of this page
Skip navigation, go straight to the content Home

UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times. The evolving COVID-19 pandemic has placed tremendous strain on medical healthcare systems worldwide as they focus on the ongoing extraordinary medical emergency. Taking this into consideration, UCB has taken measures to protect the patients we serve and others around the world.


U.S. Innovation

image description

U.S. Impact

image description

Information for Patients

image description

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases.


Latest News